1. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602. Epub 1998/05/09.
2. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002 Dec;3(6):889-901. Epub 2002/12/14.
3. Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. The Journal of biological chemistry. 1998 Aug 7;273(32):20551-5. Epub 1998/08/01.
4. Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. The EMBO journal. 2001 Mar 15;20(6):1271-80. Epub 2001/03/17.
5. Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ, et al. Syk, c- Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. The Journal of cell biology. 2007 Mar 12;176(6):877-88. Epub 2007/03/14.
6. Mocsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6158-63. Epub 2004/04/10.
7. Nakashima T, Takayanagi H. New regulation mechanisms of osteoclast differentiation. Ann N Y Acad Sci. 2011 Dec;1240:E13-8.
8. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004 Apr 15;428(6984):758-63. Epub 2004/04/16.
9. Seeling M, Hillenhoff U, David JP, Schett G, Tuckermann J, Lux A, et al. Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10729-34. Epub 2013/06/12.
10. Grevers LC, de Vries TJ, Everts V, Verbeek JS, van den Berg WB, van Lent PL. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcgamma receptors on myeloid precursor cells. Ann Rheum Dis. 2013 Feb;72(2):278-85. Epub 2012/08/25.
11. Negishi-Koga T, Gober HJ, Sumiya E, Komatsu N, Okamoto K, Sawa S, et al. Immune complexes regulate bone metabolism through FcRgamma signalling. Nat Commun. 2015 Mar 31;6:6637. Epub 2015/04/01.
12. Komarova SV, Pilkington MF, Weidema AF, Dixon SJ, Sims SM. RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. The Journal of biological chemistry. 2003 Mar 7;278(10):8286-93. Epub 2002/12/24.
13. Kajiya H, Okamoto F, Nemoto T, Kimachi K, Toh-Goto K, Nakayana S, et al. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations. Cell Calcium. 2010 Nov;48(5):260-9. Epub 2010/10/29.
14. Masuyama R, Mizuno A, Komori H, Kajiya H, Uekawa A, Kitaura H, et al. Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass. J Bone Miner Res. 2012 Aug;27(8):1708-21. Epub 2012/04/12.
15. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010 Apr;69(4):631-7. Epub 2010/03/11.
16. McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017 Jun 10;389(10086):2328-37. Epub 2017/06/15.
17. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006 Nov 27;203(12):2673-82. Epub 2006/11/08.
18. Hecht C, Schett G, Finzel S. The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritis. Ann Rheum Dis. 2015 Jan;74(1):e4. Epub 2014/10/19.
19. Takeuchi T, Tanaka Y, Ishiguro N, Yamanaka H, Yoneda T, Ohira T, et al. Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. Ann Rheum Dis. 2016 Jun;75(6):983-90. Epub 2015/11/21.
20. Bozec A, Zaiss MM, Kagwiria R, Voll R, Rauh M, Chen Z, et al. T cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathway. Sci Transl Med. 2014 May 7;6(235):235ra60. Epub 2014/05/09.
21. Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Koike T. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study. Rheumatol Int. 2018 May;38(5):777-84. Epub 2018/01/03.
22. Gibon E, Goodman SB. The Biologic Response to Bearing Materials. Orthop Knowl Online. 2016 Jun;14(6). Epub 2016/06/01.
23. Akira S. Innate immunity and adjuvants. Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2748-55. Epub 2011/09/07.
24. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010 Mar 19;140(6):805-20. Epub 2010/03/23.
25. Sabin FR, Smithburn KC, Thomas RM. Cellular Reactions to Waxes from Mycobacterium Leprae. J Exp Med. 1935 Nov 30;62(6):771-86. Epub 1935/11/30.
26. Ten Harkel B, Koopsen J, van Putten SM, van Veen H, Picavet DI, de Vries TJ, et al. Ultrastructural aspects of foreign body giant cells generated on different substrates. J Struct Biol. 2016 Jul;195(1):31-40. Epub 2016/05/08.
27. Dondossola E, Holzapfel BM, Alexander S, Filippini S, Hutmacher DW, Friedl P. Examination of the foreign body response to biomaterials by nonlinear intravital microscopy. Nat Biomed Eng. 2016;1. Epub 2016/01/01.
28. Klopfleisch R, Jung F. The pathology of the foreign body reaction against biomaterials. J Biomed Mater Res A. 2017 Mar;105(3):927-40. Epub 2016/11/05.
29. ten Harkel B, Schoenmaker T, Picavet DI, Davison NL, de Vries TJ, Everts V. The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts. PLoS One. 2015;10(10):e0139564. Epub 2015/10/02.
30. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992 Jul 1;176(1):287-92. Epub 1992/07/01.
31. Shioi A, Teitelbaum SL, Ross FP, Welgus HG, Suzuki H, Ohara J, et al. Interleukin 4 inhibits murine osteoclast formation in vitro. J Cell Biochem. 1991 Nov;47(3):272-7. Epub 1991/11/01.
32. Wei S, Wang MW, Teitelbaum SL, Ross FP. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling. The Journal of biological chemistry. 2002 Feb 22;277(8):6622-30. Epub 2001/11/24.
33. Mochizuki A, Takami M, Kawawa T, Suzumoto R, Sasaki T, Shiba A, et al. Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand. Journal of immunology (Baltimore, Md : 1950). 2006 Oct 1;177(7):4360-8. Epub 2006/09/20.
34. Helming L, Tomasello E, Kyriakides TR, Martinez FO, Takai T, Gordon S, et al. Essential role of DAP12 signaling in macrophage programming into a fusion- competent state. Sci Signal. 2008 Oct 28;1(43):ra11. Epub 2008/10/30.
35. Bakalar MH, Joffe AM, Schmid EM, Son S, Podolski M, Fletcher DA. Size- Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets. Cell. 2018 Jun 28;174(1):131-42 e13. Epub 2018/06/30.
36. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 1994 Feb 11;76(3):519-29. Epub 1994/02/11.
37. Tarik C. Gouhier, Aslak Grinsted, Viliam Simko. R package biwavelet: Conduct Univariate and Bivariate Wavelet Analyses (Version 0.20.17).
38. Akiyama T, Miyazaki T, Bouillet P, Nakamura K, Strasser A, Tanaka S. In vitro and in vivo assays for osteoclast apoptosis. Biol Proced Online. 2005;7:48-59. Epub 2005/09/02.
39. Oya A, Katsuyama E, Morita M, Sato Y, Kobayashi T, Miyamoto K, et al. Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions. J Bone Miner Metab. 2018 Nov;36(6):679-90. Epub 2017/12/24.
40. Huang KC, Yano F, Murahashi Y, Takano S, Kitaura Y, Chang SH, et al. Sandwich-type PLLA-nanosheets loaded with BMP-2 induce bone regeneration in critical-sized mouse calvarial defects. Acta Biomater. 2017 Sep 1;59:12-20. Epub 2017/07/02.
41. Hocke K, Kämpfer N. Gap filling and noise reduction of unevenly sampled data by means of the Lomb-Scargle periodogram. Atmos Chem Phys. 2009;9:4197-206.
42. Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, et al. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest. 2011 Sep;121(9):3505-16. Epub 2011/08/16.
43. Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, Kaji M, et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12- deficient mice. J Clin Invest. 2003 Feb;111(3):323-32. Epub 2003/02/06.
44. Nabbe KC, Blom AB, Holthuysen AE, Boross P, Roth J, Verbeek S, et al. Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis. Arthritis Rheum. 2003 Jan;48(1):255-65. Epub 2003/01/16.
45. van Lent PL, Grevers L, Lubberts E, de Vries TJ, Nabbe KC, Verbeek S, et al. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation. Arthritis Rheum. 2006 Dec;54(12):3868-77. Epub 2006/11/30.
46. Ruffinatti FA, Lovisolo D, Distasi C, Ariano P, Erriquez J, Ferraro M. Calcium signals: analysis in time and frequency domains. J Neurosci Methods. 2011 Aug 15;199(2):310-20. Epub 2011/06/11.
47. Tigaret CM, Tsaneva-Atanasova K, Collingridge GL, Mellor JR. Wavelet transform-based de-noising for two-photon imaging of synaptic Ca2+ transients. Biophys J. 2013 Mar 5;104(5):1006-17. Epub 2013/03/12.
48. Ruffinatti FA, Gilardino A, Lovisolo D, Ferraro M. Spatial wavelet analysis of calcium oscillations in developing neurons. PLoS One. 2013;8(10):e75986. Epub 2013/10/25.
49. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nature reviews Immunology. 2002 Feb;2(2):116-26. Epub 2002/03/26.
50. Okada H, Kajiya H, Omata Y, Matsumoto T, Sato Y, Kobayashi T, et al. CTLA4-Ig directly inhibits osteoclastogenesis by interfering with intracellular calcium oscillations in bone marrow macrophages. J Bone Miner Res. 2019 May 8. Epub 2019/05/09.
51. Miron RJ, Bosshardt DD. Multinucleated Giant Cells: Good Guys or Bad Guys? Tissue Eng Part B Rev. 2018 Feb;24(1):53-65. Epub 2017/08/22.
52. Spiller KL, Nassiri S, Witherel CE, Anfang RR, Ng J, Nakazawa KR, et al. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. Biomaterials. 2015 Jan;37:194-207. Epub 2014/12/03.